TRASTUZUMAB AND HYALURONIDASE-OYSK

107 reported adverse events

Drug classes: Endoglycosidase [EPC] HER2/neu Receptor Antagonist [EPC]

These side effects are most commonly reported by patients taking TRASTUZUMAB AND HYALURONIDASE-OYSK:

# Side effect Count
0 NO ADVERSE EVENT 30
1 OFF LABEL USE 23
2 INJECTION SITE PAIN 8
3 DIARRHOEA 7
4 PRODUCT STORAGE ERROR 7
5 NAUSEA 6
6 PAIN 6
7 NEUROPATHY PERIPHERAL 5
8 DEATH 4
9 FATIGUE 4
See all common reactions for TRASTUZUMAB AND HYALURONIDASE-OYSK

TRASTUZUMAB AND HYALURONIDASE-OYSK is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED HAEMOGLOBINOPATHY 1 0.2000
1 CRYOTHERAPY 1 0.0135
2 TESTICULAR FAILURE 1 0.0073
3 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
4 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
5 TONGUE EXFOLIATION 1 0.0028
6 TOTAL LUNG CAPACITY ABNORMAL 1 0.0026
7 FACTOR V LEIDEN MUTATION 1 0.0025
8 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
9 LOCAL REACTION 1 0.0013
See all enriched reactions for TRASTUZUMAB AND HYALURONIDASE-OYSK